Method for topical treatment of carpal tunnel syndrome
OwnerWilson T. Crandallinventor
Life of this patent
Estimating the term…
Abstract
This invention relates to the topical treatment of the Carpal Tunnel Syndrome by the use of a selected protein kinase C inhibitor and an effective penetrating agent selected from Lecithin organogel or poloxamer 407 lecithin organogel. The protein kinase C inhibitors may be selected from sphingosine, sphinganine, phytosphingosine, curcumin, tetrahydrocurcumin, curcuminoids or apigenin
Claims7
1 A method for treating carpal tunnel syndrome comprising the step of topically applying an effective amount of a Protein Kinase C inhibitor, wherein said Protein kinase C inhibitor is selected from the group consisting of phytosphingosine, tetrahydrocurcumin & curcuminoids and a pharmaceutically effective penetrating agent selected from the group consisting of lecithin organogel and poloxamer 407 lecithin organogel.
The method according to claim 1, wherein the flexor tendons of the hand are treated by applying the PKC inhibitor in a pharmaceutically effective penetrating agent on the medial wrist at the carpal tunnel.
The method of claim 1, wherein the scar in the carpal tunnel and tendon sheaths is treated by applying the PKC inhibitor in a pharmaceutically genetrating agent on the medial wrist at the carpal tunnel
4 The method according to claim 1, wherein said pharmaceutically effective penetrating agent is in the form selected from the group consisting of gels, creams, sprays, salves, balms, liposomes, micelles and pads.
5 The method according to claim 1, wherein the protein kinase C inhibitor is phytosphingosine.
The method of claim 1, wherein the protein kinase C inhibitor is tetrahydrocurcumin.
7 The method according to claim 1, wherein the protein kinase C inhibitor is a curcuminoid
- Therefore it is submitted that patentable subject matter is clearly present. If the Examiner agrees but doesn't feel that the present claims are not technically adequate , applicant respectfully requests that the examine write acceptable claims pursuant to MPEP 707.07
Dependencies are inferred from the claim text.